• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Sanofi Aventis (SNY)’

Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock

On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report at the U.S.

Keep Reading →

January 29 - Insider Trading, News - Comments

Abrams Capital Management Trims the Stake in Engility Holdings Inc (EGL)

Abrams Capital Management, led by David Abrams significantly trimmed its stake in Engility Holdings Inc (NYSE:EGL).

Keep Reading →

December 30 - Hedge Funds, News - Comments

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there's a defined time period when we expect it to occur, yet it seems to appear earlier and earlier every year.

Keep Reading →

September 23 - News - Comments

Four Reasons to Buy This Biotechnology Stock

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best performing stocks in the ...

Keep Reading →

September 20 - News - Comments

Sanofi SA (ADR) (SNY), Biodel Inc (BIOD): Would It Be Foolish to Trust Unilife Corp (UNIS)?

Shares of drug delivery systems manufacturer Unilife Corp (NASDAQ:UNIS) recently rallied after it announced a long-term contract to sell prefilled syringes to pharma giant Sanofi...

Keep Reading →

September 18 - News - Comments

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

There is perhaps nothing scarier than a cancer diagnosis.

Keep Reading →

September 17 - News - Comments

Regeneron Pharmaceuticals Inc (REGN): Should You Follow in Sanofi SA (ADR) (SNY)’s Footsteps and Invest in This Booming Biotech?

More than anything, biotech companies need investors who are true believers in their products.

Keep Reading →

September 17 - News - Comments

Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Getting Closer

French drugmaker Sanofi SA (ADR) (NYSE:SNY) counted that much money in its coffers as of the end of June, including cash, cash equivalents, and short-term investments.

Keep Reading →

September 17 - News - Comments

Sanofi SA (ADR) (SNY), Shire PLC (ADR) (SHPG): Making Sense of the Drama About Viropharma Inc (VPHM)

In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well-known for its hefty acquisition...

Keep Reading →

September 16 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors

Looking for the best-performing sector in this year's big market rally? It may just be the biotech sector, which has erupted with astronomical gains in 2013.

Keep Reading →

September 16 - News - Comments

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation

There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ:KERX) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston.

Keep Reading →

September 15 - News - Comments

GameStop Corp. (GME), Safeway Inc. (SWY), Regeneron Pharmaceuticals Inc (REGN): Friday’s Three Best Stocks

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...

Keep Reading →

September 14 - News - Comments

Apple Inc. (AAPL), NIKE, Inc. (NKE): The Mobile Future of Diabetes Treatments

In my opinion, the Nike+ FuelBand released by Apple Inc. (NASDAQ:AAPL) and NIKE, Inc. (NYSE:NKE) last year was a seminal product in health care tech.

Keep Reading →

September 11 - News - Comments

Sanofi SA (ADR) (SNY), Biodel Inc (BIOD): When Will Unilife Corp (UNIS) Earnings Go Positive?

Unilife Corp (NASDAQ:UNIS) will release its quarterly report on Tuesday, but investors already have reason to believe that the company won't make a profit.

Keep Reading →

September 9 - News - Comments

Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits

Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will avoid losing money again...

Keep Reading →

September 5 - News - Comments

Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?

As an investor in the health care sector, it can sometimes feel like everything -- and everyone -- is out to get you.

Keep Reading →

August 30 - News - Comments

Allergan, Inc. (AGN), Sanofi SA (ADR) (SNY): New FDA Guidelines Hit This Company Hard

Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products.

Keep Reading →

August 30 - News - Comments

Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health

In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets.

Keep Reading →

August 29 - News - Comments

Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player

Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab.

Keep Reading →

August 27 - News - Comments

Peregrine Pharmaceuticals (PPHM), Sanofi SA (ADR) (SNY): Is This Experimental Lung Cancer Drug Back on Track?

Peregrine Pharmaceuticals (NASDAQ:PPHM), a developmental stage biotech focusing on oncology treatments, recently announced that its lead drug candidate, bavituximab, was heading...

Keep Reading →

August 23 - News - Comments

Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN): Are These Drugs the Future of High-Cholesterol Treatment?

Once upon a time in a regulatory environment far, far away, there was a cholesterol-fighting drug named Lipitor from Pfizer Inc. (NYSE:PFE).

Keep Reading →

August 21 - News - Comments

Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis

It's a disease that doesn't often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are focusing their efforts on to make a quality...

Keep Reading →

August 19 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY): This Pharma Stock Is Ready to Reach New Heights

Earlier this year, in May, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was soaring on news of FDA approval of the Eylea injection.

Keep Reading →

August 12 - News - Comments

Dendreon Corporation (DNDN), Merrimack Pharmaceuticals Inc (MACK), Novavax, Inc. (NVAX): Three Horrendous Health-Care Stocks This Week

August might be hot for most of the country, but the first full week of the month wasn't so hot for some stocks.

Keep Reading →

August 12 - News - Comments

GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor

With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the...

Keep Reading →

August 12 - News - Comments

Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY): Is This Biotech Slowing?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) closed Tuesday down over 6% following a second quarter report that missed estimates.

Keep Reading →

August 9 - News - Comments

Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On

Currently existing immunomodulatory drugs that treat Multiple Sclerosis only work to treat relapse or attacks, manage symptoms, or modify the course of the disease.

Keep Reading →

August 8 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO

The Motley Fool's readers have spoken, and I have heeded their cries.

Keep Reading →

August 7 - News - Comments

Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape

As human beings it can sometimes be difficult for us to see the good in a bad situation.

Keep Reading →

August 7 - News - Comments

Pfizer Inc. (PFE), Amgen, Inc. (AMGN): The Best-Selling Medications of 2013 (So Far)

Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits thus far in the year.

Keep Reading →

August 6 - News - Comments

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Will Zoetis Earnings Deliver on Post-Spinoff Growth?

Zoetis will release its quarterly report on Tuesday, and investors will get their first look at the company as a completely independent business entity.

Keep Reading →

August 5 - News - Comments

Array Biopharma Inc (ARRY), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Ways Your Kids Can Be Harmed by Smog

Around four in 10 Americans live in places where smog can impact their health.

Keep Reading →

August 5 - News - Comments

Will Regeneron Pharmaceuticals Inc (REGN) Earnings Grow Fast Enough for Investors?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will release its quarterly report on Tuesday, and the company's stock has been on an absolute tear over the past year.

Keep Reading →

August 2 - News - Comments

Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday.

Keep Reading →

August 1 - News - Comments

Novo Nordisk A/S (ADR) (NVO): Three Shocking Numbers on Diabetes’ Grim Future

Diabetes is one of the world's most dangerous and fastest-growing afflictions.

Keep Reading →

August 1 - News - Comments

Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS

Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)'s recent earnings report is a key confirmation of a shifting market in the treatment of multiple sclerosis...

Keep Reading →

August 1 - News - Comments

Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War

It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not require medication.

Keep Reading →

August 1 - News - Comments

Things You Need to Know From Questcor Pharmaceuticals Inc (QCOR)’s Killer Q2 Earnings

Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad as they looked.

Keep Reading →

July 31 - News - Comments

The Procter & Gamble Company (PG), Merck & Co., Inc. (MRK): The Six Biggest Risk Factors for Insomnia

We often take sleep, the number of hours we get to sleep, or the quality of sleep we get, for granted.

Keep Reading →

July 29 - News - Comments

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow.

Keep Reading →

July 26 - News - Comments

Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)

The "people familiar with the matter" are out in full force spouting off about who's bidding for Onyx Pharmaceuticals, Inc.

Keep Reading →

July 19 - News - Comments

Merck & Co., Inc. (MRK)’s Late-Stage Breakdown

The Food and Drug Administration cancelled an advisory meeting planned for Merck & Co., Inc. (NYSE:MRK)’s post-surgery drug sugammadex.

Keep Reading →

July 19 - News - Comments

The Future of Sanofi SA (ADR) (SNY)’s Insulin Empire

Sanofi SA (ADR) (NYSE:SNY) appeared at the American Diabetes Association meeting last month, touting data for the new insulin U300 and a combo therapy involving its approved drugs...

Keep Reading →

July 18 - News - Comments

Could This Safe Play Help Eli Lilly & Co. (LLY)?

At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.

Keep Reading →

July 12 - News - Comments

Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target

The Orphan Drug pipeline of BioMarin Pharmaceutical Inc.

Keep Reading →

July 11 - News - Comments

Could This Safe Play Help Eli Lilly & Co. (LLY)?

At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide.

Keep Reading →

July 10 - News - Comments

The Boeing Company (BA), Lockheed Martin Corporation (LMT) – Pentagon Watch: Where Did Your Tax Dollars Go This Week?

The U.S. military has a reputation as a somewhat secretive organization. But in one respect at least, the Pentagon ranks among our most transparent government agencies.

Keep Reading →

July 8 - News - Comments

Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)

Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.

Keep Reading →

July 5 - News - Comments

Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World

The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016.

Keep Reading →

July 3 - News - Comments

AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks

Healthcare stocks have rallied over the past couple years, and for good reason.

Keep Reading →

June 28 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

10 Biggest Online Streaming Companies in the World

10 Biggest Online Streaming Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable E-Commerce Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Software Companies in the World

15 Most Valuable Platform Companies in the World

15 Most Valuable Platform Companies in the World

10 Biggest Crypto Companies in the World

10 Biggest Crypto Companies in the World

11 Best Augmented Reality Stocks to Invest In

11 Best Augmented Reality Stocks to Invest In

10 Best Plant Based Companies to Invest In

10 Best Plant Based Companies to Invest In

10 Best Tech Stocks to Buy For The Long Term

10 Best Tech Stocks to Buy For The Long Term

Naval Ravikant’s Latest Investment Portfolio: 10 Companies to Watch

Naval Ravikant’s Latest Investment Portfolio: 10 Companies to Watch

13 Most Ambitious Metaverse Companies in the World

13 Most Ambitious Metaverse Companies in the World

10 Most Profitable Biotech Companies in the World

10 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

5 Most Profitable Biotech Companies in the World

10 Cryptocurrencies Millionaires Love

10 Cryptocurrencies Millionaires Love

5 Largest Chip Producers In The World

5 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Largest Chip Producers In The World

12 Biggest Agriculture Companies in the World

12 Biggest Agriculture Companies in the World

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

10 Cryptocurrencies To Buy and Hold for the Next 10 Years

5 Biggest Green Energy Companies in the World

5 Biggest Green Energy Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Real Estate Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable Korean Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable UK Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Japanese Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable Beer Companies in the World

15 Most Valuable German Companies

15 Most Valuable German Companies

5 Most Valuable German Companies

5 Most Valuable German Companies

15 Most Valuable Government-Owned Companies in the World

15 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

5 Most Valuable Government-Owned Companies in the World

10 3D Printing Companies to Watch in 2022

10 3D Printing Companies to Watch in 2022

25 Safest Countries in the World

25 Safest Countries in the World

5 Safest Countries in the World

5 Safest Countries in the World

25 Most Aggressive Dog Breeds in America

25 Most Aggressive Dog Breeds in America

25 Most Popular Dog Breeds in the World

25 Most Popular Dog Breeds in the World

50 Things to Do When Bored

50 Things to Do When Bored

15 Most Valuable New Zealand Companies in the World

15 Most Valuable New Zealand Companies in the World

Top 15 Most Valuable Italian Companies

Top 15 Most Valuable Italian Companies

Top 22 Packaging Companies in USA

Top 22 Packaging Companies in USA

25 Best Countries in the World

25 Best Countries in the World

30 Easy Things to Draw When You are Bored

30 Easy Things to Draw When You are Bored

15 Most Valuable Space Companies in the World

15 Most Valuable Space Companies in the World

15 Most Valuable Cigarette Companies in the World

15 Most Valuable Cigarette Companies in the World

10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors

10 Pharmaceutical Stocks to Buy According to Brandon Haley’s Holocene Advisors

15 Most Valuable Data Companies in the World

15 Most Valuable Data Companies in the World

15 Most Anticipated Movies of 2021 and 2022

15 Most Anticipated Movies of 2021 and 2022

21 Best Android Phones to Buy for 2021

21 Best Android Phones to Buy for 2021

15 Most Valuable South African Companies

15 Most Valuable South African Companies

15 Cheapest New Cars for 2021

15 Cheapest New Cars for 2021

25 Most Expensive Cars in the World

25 Most Expensive Cars in the World

30 Most Valuable Publicly Traded Defense Companies In The World

30 Most Valuable Publicly Traded Defense Companies In The World

15 Affordable Liberal Cities in America

15 Affordable Liberal Cities in America

15 Fastest Growing Fast Food Chains

15 Fastest Growing Fast Food Chains
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.